{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:15:04Z","timestamp":1778220904802,"version":"3.51.4"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>High-grade neuroendocrine carcinoma (NEC) can be difficult to diagnose, particularly when conventional neuroendocrine (NE) markers are weakly expressed or absent. This challenge is particularly pronounced in NE-low tumors with lineage-defining transcription factor profiles (e.g., POU2F3 and\/or YAP1), which may exhibit squamoid (basal-like) morphology and reduced or absent expression of synaptophysin (Syn), chromogranin A (CgA), and CD56, thereby phenotypically overlapping with non-small cell lung cancer (NSCLC) and increasing the risk of misclassification. In this case, needle biopsies from the lung and liver both showed a poorly differentiated carcinoma with squamoid morphology and squamoid\/basal-like immunohistochemical features. Syn, CgA, and CD56 were negative in both specimens, leading to an initial diagnosis of poorly differentiated squamous cell carcinoma. However, the subsequent clinical course revealed discordant clinicobiologic features, including rapid progression of the liver metastases, markedly elevated NSE levels, and a high Ki-67 labeling index (60\u201380%). These discrepancies prompted further molecular evaluation, and 90-gene expression profiling (90-GEP) supported a neuroendocrine lineage assignment. Retrospective immunohistochemistry further demonstrated positivity for POU2F3 and YAP1, whereas INSM1 was negative in both specimens, supporting classification as an NE-marker\u2013negative high-grade NEC with an NE-low NEC\/SCLC-like lineage profile. The patient subsequently showed a marked response to etoposide plus carboplatin, consistent with the known chemosensitivity of high-grade NEC\/SCLC to platinum-based chemotherapy. This case highlights an underrecognized diagnostic pitfall of NE-marker\u2013negative high-grade NEC with squamoid mimicry. When morphology, immunophenotype, and clinical behavior are discordant, integration of expanded immunohistochemistry (including lineage-defining transcription factors), molecular lineage assays (e.g., GEP), and treatment response may help avoid misdiagnosis and guide appropriate therapy.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1766781","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:52:44Z","timestamp":1778219564000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Neuroendocrine-marker\u2013negative high-grade neuroendocrine carcinoma mimicking squamous cell carcinoma: an underrecognized diagnostic pitfall"],"prefix":"10.3389","volume":"17","author":[{"given":"Wen","family":"He","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Suzhou Ninth Hospital Affiliated to Soochow University","place":["Suzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Suzhou Ninth Hospital Affiliated to Soochow University","place":["Suzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Suzhou Ninth Hospital Affiliated to Soochow University","place":["Suzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Suzhou Ninth Hospital Affiliated to Soochow University","place":["Suzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuyang","family":"You","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Suzhou Ninth Hospital Affiliated to Soochow University","place":["Suzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaozhen","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Suzhou Ninth Hospital Affiliated to Soochow University","place":["Suzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1646608","article-title":"A comparison of clinical guidelines, treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe\/North America","volume":"15","author":"Chiang","year":"2025","journal-title":"Front Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.21037\/tlcr.2018.01.16","article-title":"Current standards for clinical management of small cell lung cancer","volume":"7","author":"Farago","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41379-021-00943-2","article-title":"Lung neuroendocrine neoplasms: recent progress and persistent challenges","volume":"35","author":"Rekhtman","year":"2022","journal-title":"Mod Pathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.06.004","article-title":"POU2F3 in SCLC: Clinicopathologic and genomic analysis with a focus on its diagnostic utility in neuroendocrine-low SCLC","volume":"17","author":"Baine","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.09.009","article-title":"SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: A comprehensive immunohistochemical and histopathologic characterization","volume":"15","author":"Baine","year":"2020","journal-title":"J Thorac Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0133-9","article-title":"Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data","volume":"19","author":"Rudin","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.12.014","article-title":"Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities","volume":"39","author":"Gay","year":"2021","journal-title":"Cancer Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1101\/gad.314815.118","article-title":"POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer","volume":"32","author":"Huang","year":"2018","journal-title":"Genes Dev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00313-9","article-title":"Site-specific therapy guided by a 90-gene expression assay versus empirical chemotherapy in patients with cancer of unknown primary (Fudan CUP-001): a randomised controlled trial","volume":"25","author":"Liu","year":"2024","journal-title":"Lancet Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.15608","article-title":"Benefit of gene expression profiling in gastrointestinal neuroendocrine tumors of unknown primary origin","volume":"42","author":"Saller","year":"2022","journal-title":"Anticancer Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.3755","article-title":"Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute","volume":"31","author":"Hainsworth","year":"2013","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.humpath.2019.12.002","article-title":"Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you","volume":"96","author":"Bellizzi","year":"2020","journal-title":"Hum Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.150","article-title":"Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas","volume":"25","author":"Travis","year":"2012","journal-title":"Mod Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2020.02.13","article-title":"Multiple faces of pulmonary large cell neuroendocrine carcinoma: update with a focus on practical approach to diagnosis","volume":"9","author":"Baine","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqz149","article-title":"A semiquantitative scoring system may allow biopsy diagnosis of pulmonary large cell neuroendocrine carcinoma","volume":"153","author":"Baine","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2017.06.12","article-title":"Update on large cell neuroendocrine carcinoma","volume":"6","author":"Hiroshima","year":"2017","journal-title":"Transl Lung Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000002081","article-title":"POU2F3: A sensitive and specific diagnostic marker for neuroendocrine-low\/negative small cell lung cancer","volume":"47","author":"Wang","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6721","article-title":"Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells","volume":"7","author":"Cheng","year":"2016","journal-title":"Oncotarget"},{"key":"B21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jasc.2019.06.002","article-title":"Insulinoma-associated protein 1 is a sensitive and specific marker for lung neuroendocrine tumors in cytologic and surgical specimens","volume":"8","author":"Viswanathan","year":"2019","journal-title":"J Am Soc Cytopathol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70195","article-title":"Transcriptional profiling directs the classification of acute leukemias of ambiguous lineage into AML, B-ALL, or T-ALL","volume":"9","author":"Mulet-Lazaro","year":"2025","journal-title":"Hemasphere"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.13062","article-title":"P40 expression in small cell lung cancer: The presence of p40-positive cells does not always indicate squamous differentiation","volume":"10","author":"Nakajima","year":"2019","journal-title":"Thorac Cancer"},{"key":"B24","article-title":"Expression of p63, p40 and CK5\/6 in small cell lung cancer","volume":"44","author":"Zhang","year":"2015","journal-title":"Zhonghua Bing Li Xue Za Zhi"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1766781\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:53:06Z","timestamp":1778219586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1766781\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":24,"alternative-id":["10.3389\/fimmu.2026.1766781"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1766781","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"article-number":"1766781"}}